The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents
Cancer is a major health problem across the globe, and is expeditiously growing at a faster rate worldwide. The endoplasmic reticulum (ER) is a membranous cell organelle having inextricable links in cellular homeostasis. Altering ER homeostasis initiates various signaling events known as the unfolde...
Main Authors: | Roohi Mohi-ud-din, Reyaz Hassan Mir, Taha Umair Wani, Khalaf F. Alsharif, Waqas Alam, Ashraf Albrakati, Luciano Saso, Haroon Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/8/2471 |
Similar Items
-
Luteolin inhibits ER-α expression through ILK inhibition is regulated by a pathway involving Twist and YB-1
by: Ying-Chao Lin, et al.
Published: (2018-03-01) -
Natural Polyphenols as SERCA Activators: Role in the Endoplasmic Reticulum Stress-Related Diseases
by: Jana Viskupicova, et al.
Published: (2022-08-01) -
Protective effect of luteolin on the transgenic Drosophila model of Parkinson’s disease
by: Yasir Hasan Siddique, et al.
Published: (2018-11-01) -
Luteolin 7-Sulfate Attenuates Melanin Synthesis through Inhibition of CREB- and MITF-Mediated Tyrosinase Expression
by: Seok Won Lee, et al.
Published: (2019-04-01) -
Endoplasmic reticulum-targeting nanomedicines for cancer therapy
by: Yi Liu, et al.
Published: (2021-01-01)